MARKET

MDCO

MDCO

Medicines
NASDAQ

Real-time Quotes | Nasdaq Last Sale

84.21
+0.31
+0.37%
After Hours: 84.18 -0.03 -0.04% 17:48 12/06 EST
OPEN
84.00
PREV CLOSE
83.90
HIGH
84.24
LOW
83.99
VOLUME
3.00M
TURNOVER
--
52 WEEK HIGH
84.30
52 WEEK LOW
16.69
MARKET CAP
6.73B
P/E (TTM)
-26.8870
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MDCO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 10 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

MDCO News

  • Can Cannabis 2.0 Kickstart Marijuana Stocks?
  • MotleyFool.com.1d ago
  • SHAREHOLDER ALERT: Monteverde & Associates PC Continues its Investigation on the Following Transaction
  • ACCESSWIRE.1d ago
  • Companies Are Merging Like Mad. That Might Signal a Looming Economic Slowdown.
  • Barrons.com.1d ago
  • Novartis Tender Offer for The Medicines Company Commences
  • Benzinga.2d ago

More

Industry

Pharmaceuticals
+0.45%
Pharmaceuticals & Medical Research
+0.49%

Hot Stocks

Name
Price
%Change

About MDCO

The Medicines Company is a global biopharmaceutical company. The Company is focused on advancing the treatment of acute and intensive care patients through the delivery of medicines to the hospital marketplace around the world. It markets Angiomax (bivalirudin), Ionsys (fentanyl iontophoretic transdermal system), Minocin (minocycline) for injection and Orbactiv (oritavancin). It also has a pipeline of products in development, including Carbavance, inclisiran and MDCO-700. Carbavance is used for the treatment of hospitalized patients with gram-negative bacterial infections. Inclisiran is used for the treatment of hypercholesterolemia. MDCO-700 includes sedative-hypnotic, which is used to induce and maintain sedation for procedural care and general anesthesia for surgical care. In addition to these products and products in development, it has a portfolio of generic drugs.
More

Webull offers The Medicines Company (MDCO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.